Bivona, Trever G
Doebele, Robert C
Article History
Received: 25 August 2015
Accepted: 23 March 2016
First Online: 5 May 2016
Competing interests
: T.G.B. has ownership in Driver Group, is a consultant to Driver Group, Novartis, Astellas, Natera, Array Biopharma, and Ariad, and is a recipient of research grants from Servier and Ignyta. R.C.D. is a consultant to Array BioPharma and Ariad, and has received honoraria from AstraZeneca, Clovis, and Pfizer, research grants from Loxo Oncology, Mirati Therapeutics, and Abbott Molecular, and licensing fees from Chugai, Ariad, Blueprint Medicines, GVKbio, and Abbott Molecular.